Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Foreign Patients Are Flying to Thailand for Aesthetic Care — and Aura Bangkok Clinic Is a Destination of Choice
EIN Presswire
Thailand's non-invasive aesthetics sector is emerging as a regional force, its distinctly Thai, diversity-led beauty philosophy rising beside Korea and Japan.
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
GlobeNewswire, Inc.
About lecanemab (generic name, brand name: LEQEMBI®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic.
AMLC leverages global excess medical inventory to boost joint, reserve readiness
DVIDS - Georgia
FORT DETRICK, Md. – Instead of marking excess or expired medical supplies for disposal, U.S. Army Medical Logistics Command gives divested materiel a critical second life.
Endurance Energy Gels Market to Reach USD 1.06 Billion by 2034 as Sports Nutrition Embraces Precision Fuelling
EIN Presswire
Endurance Energy Gels Market valued at USD 635 Million in 2025, projected to reach USD 1,062 Million by 2034, expanding at a 7.7% CAGR. PUNE, MAHARASHTRA, INDIA, August 31, 2026 /EINPresswire.com/ -- Endurance Energy Gels Market is entering a...
Penta Security Launches D.AMO onOS v5.0 for Unstructured Data Encryption
EIN Presswire
SEOUL, SOUTH KOREA, September 2, 2026 /EINPresswire.com/ -- Penta Security, a cybersecurity company, announced the launch of D.AMO onOS v5.0, an unstructured data encryption solution designed to comprehensively protect unstructured data in Linux...
Leios Therapeutics Announces Exclusive Licensing Agreement and Strategic Investment with Subsidiaries of China Medical System Holdings Ltd. for 10XB-101
GlobeNewswire, Inc.
10XB-101 is a Novel Potential Best-in-Class Injectable Drug Being Developed for Focal Fat Reduction and Body Contouring Second Major Regional Licensing and Strategic Investment Agreement in 2026; Further Validates 10XB-101 Global Commercial Market...
‘Busan Syndrome’ Gains Visibility as Busan, South Korea, Opens Citywide Night Festa
EIN Presswire
American visits to Busan up 76% this year as South Korea's leading coastal destination expands free nighttime programming through December.
Medical Aesthetics Market to reach USD 51.35 Billion by 2035 at 10.93% CAGR
EIN Presswire
Medical Aesthetics Market to Surge from USD 20.19 Billion in 2026 to USD 51.35 Billion by 2035—Powered by Rising Geriatric Population, Social Media Awareness NY, CA, UNITED STATES, August 26, 2026 /EINPresswire.com/ -- As per Market Research...
Global Skin Care Products Market is Expected to Surpass the USD 260 Billion Mark by 2034 | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Global Skin Care Products Market is Expected to Surpass the USD 260 Billion Mark by 2034 | DelveInsight The skin care products market is experiencing steady growth, driven by rising consumer...
South Korea’s VandS Clinic Expands Multilingual Aesthetic Care for Global Tourists
EIN Presswire
VandS Clinic offers tailored diagnostic treatments and interpretation support across 68 South Korean branches to serve international travelers.
Ear Balance to Expand Specialist Audiology Care with New Thomson Medical Centre Clinic in 2027
EIN Presswire
SINGAPORE, SINGAPORE, August 24, 2026 /EINPresswire.com/ -- Ear Balance, a specialist hearing and balance clinic in Singapore, is preparing to expand its clinical services with the opening of a new clinic at Thomson Medical Center in January...
Biopharmaceuticals Market to reach USD 764.9 Billion by 2035 at 6.6% CAGR
EIN Presswire
Biopharmaceuticals Market to Surge from USD 401.6 Billion in 2025 to USD 764.9 Billion by 2035—By Rising Chronic Disease Burden, Oncology Pipeline Density NY, CA, UNITED STATES, September 2, 2026 /EINPresswire.com/ -- As per Market Research...
A2 Milk Market Set to Reach USD 90.77 Billion by 2035 at 17.75% CAGR as Health-Focused Dairy Demand Accelerates
EIN Presswire
The A2 Milk Market is projected to grow from USD 17.71 billion in 2025 to USD 90.77 billion by 2035, driven by health-focused dairy demand.
Manuka Honey Market Reaches USD 1.291 Billion by 2035 at 6.0% CAGR as Natural Wellness Demand Accelerates
EIN Presswire
Manuka Honey Market is projected to grow from USD 0.7208 billion in 2025 to USD 1.291 billion by 2035 at a 6.0% CAGR, supported by natural wellness demand.
Flavor Market to Reach USD 34.0 Billion by 2035 at 6.40% CAGR as Natural and Health-Focused Flavors Drive Innovation
EIN Presswire
Flavor Market is projected to reach USD 34.0 billion by 2035, driven by natural ingredients, product innovation, & evolving consumer taste preferences.
Olympian Joetta Clark Diggs to Compete at World Masters Athletics Championships in Daegu, South Korea
EIN Presswire
Decorated Olympian and American record-holder will compete in the 100-meter and 200-meter events on the international masters stage BETHLEHEM, PA, UNITED STATES, August 20, 2026 /EINPresswire.com/ -- Four-time U.S. Olympian, 11-time USA national...
Sofwave Surpasses One Million Treatments Worldwide; Milestone Treatment Performed in South Korea
GlobeNewswire, Inc.
SAN CLEMENTE, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd. (TASE: SOFW), a global regenerative aesthetics company advancing non-invasive technologies for skin and body, today announced that it has surpassed one million Sofwave®...
Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
GlobeNewswire, Inc.
ENIGMA-TRS 1 is a Phase 3 international, one-year, randomized, double-blind, placebo-controlled study in 600+ patients; 12-week study results expected in Q1 2027 Evenamide, a first-in-class glutamate modulator, has the potential to be the first...
AB Plastic Surgery Clinic Reports 'Zero Medical Accidents,' Citing Integrated Patient Safety System
EIN Presswire
Korea based AB Plastic Surgery Clinic highlights its integrated approach to anesthesia, real time monitoring, emergency preparedness and patient safety.
Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition
GlobeNewswire, Inc.
NBI-1117567 is an investigational oral, muscarinic M1 preferring (M1/M4) selective agonist discovered by Nxera and advancing through clinical development under a multi-program collaboration with Neurocrine Nxera to receive a US$10 million...
Sign up for:
Health Daily South Korea
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.